ConductScience.org, home

Paper18958751

Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.

Brodsky RA and 1 other. Autoimmunity, 2008. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages. Papers, record 18958751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18958751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages.
PubMed
Journal
Autoimmunity
PubMed
Year
2008
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.43
iCite
Revised in PubMed
2025-05-29
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brodsky RARobert A
2Jones RJRichard J

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Autoimmune DiseasesMajor topic
CyclophosphamideMajor topic
Immunosuppressive AgentsMajor topic
Dose-Response Relationship, Immunologic
Humans
Stem Cell Transplantation

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P01 CA015396NCI NIH HHSUnited StatesP01CA015396PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18555470Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation.Blood1996https://conductscience.org/library/papers/8555470PubMed
215090586High dose cyclophosphamide for severe refractory myasthenia gravis.J Neurol Neurosurg Psychiatry2004https://conductscience.org/library/papers/15090586PubMed
3773651Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia.Exp Hematol1976https://conductscience.org/library/papers/773651PubMed
417252566Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide.Pediatr Blood Cancer2007https://conductscience.org/library/papers/17252566PubMed
511100024Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris.J Am Acad Dermatol2000https://conductscience.org/library/papers/11100024PubMed
67742535Assessment of aldehyde dehydrogenase in viable cells.Blood1995https://conductscience.org/library/papers/7742535PubMed
76488175Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia.Cancer Res1984https://conductscience.org/library/papers/6488175PubMed
811114821Treatment of severe aplastic anemia using high-dose cyclophosphamide alone in China.Haematologica2000https://conductscience.org/library/papers/11114821PubMed
915885298Aplastic anaemia.Lancet2005https://conductscience.org/library/papers/15885298PubMed
1012084892High-dose cyclophosphamide without stem-cell rescue for refractory CIDP.Neurology2002https://conductscience.org/library/papers/12084892PubMed
1117133541Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens.Arthritis Rheum2006https://conductscience.org/library/papers/17133541PubMed
1215765114Autologous hematopoietic stem cell transplantation for autoimmune diseases.Bone Marrow Transplant2005https://conductscience.org/library/papers/15765114PubMed
134109931Aplastic anaemia treated by marrow transplantation.Lancet1972https://conductscience.org/library/papers/4109931PubMed
1412195780High-dose cyclophosphamide for severe systemic lupus erythematosus.Lupus2002https://conductscience.org/library/papers/12195780PubMed
15319010Recovery of hematologic competence without engraftment following attempted bone marrow transplantation for aplastic anemia: Report of a case with diffusion chamber studies.Exp Hematol1977https://conductscience.org/library/papers/319010PubMed
169867758Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease.Ann Intern Med1998https://conductscience.org/library/papers/9867758PubMed
1711426504High-dose cyclophosphamide in the treatment of severe aplastic anemia in children.Am J Hematol2001https://conductscience.org/library/papers/11426504PubMed
1812717089Remission of severe autoimmune enteropathy after treatment with high-dose cyclophosphamide.J Pediatr Gastroenterol Nutr2003https://conductscience.org/library/papers/12717089PubMed
1912528116High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.Arthritis Rheum2003https://conductscience.org/library/papers/12528116PubMed
2011306068Genetic dissection of retinoid dehydrogenases.Chem Biol Interact2001https://conductscience.org/library/papers/11306068PubMed

See all 35 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
39576169High-dose Cyclophosphamide Without Stem Cell Rescue in Autoimmune Diseases: A Systematic Review.Eur J Rheumatol2024https://conductscience.org/library/papers/39576169PubMed
27313069Improved Behavior and Neuropsychological Function in Children With ROHHAD After High-Dose Cyclophosphamide.Pediatrics2016https://conductscience.org/library/papers/27313069PubMed
22969816Hematopoietic stem cell transplantation for systemic lupus erythematosus.Clin Dev Immunol2012https://conductscience.org/library/papers/22969816PubMed
21304001Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features.Clin Cancer Res2011https://conductscience.org/library/papers/21304001PubMed
21295330High-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's disease.Semin Arthritis Rheum2011https://conductscience.org/library/papers/21295330PubMed
20727534Cyclophosphamide for rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome.J Pediatr2011https://conductscience.org/library/papers/20727534PubMed
20581881Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I.Bone Marrow Transplant2011https://conductscience.org/library/papers/20581881PubMed
20087683High-dose cyclophosphamide for autoimmunity and alloimmunity.Immunol Res2010https://conductscience.org/library/papers/20087683PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKR1A110327PubTator's text mininghttps://conductscience.org/library/genes/10327NCBI Gene
ALDH1A1216PubTator's text mininghttps://conductscience.org/library/genes/216NCBI Gene
CYP4F34051PubTator's text mininghttps://conductscience.org/library/genes/4051NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18958751

GET https://conductscience.org/api/papers/v1/18958751/references?page=2